METHYL 7-(TRIFLUOROMETHYL)-1H-INDAZOLE-5-CARBOXYLATE, 95.0%, 1g

2-[(cyclopropylcarbonyl)amino]-1,3-oxazole-4-carboxylic acid, 95.0%, 500mg

4-Bromo-2-ethoxy-6-fluorobenzaldehyde, 250mg

H-DL-Pro-OH, 98%, 10g

6-(tert-butyl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 2.5g

1-((4-Bromo-2-methylphenyl)sulfonyl)piperidine, 97%, 1g

2,4-Dichloro-3-cyano-5-fluorobenzoic acid, 95.0%, 5g

2-Propoxyphenylboronic acid, 95.0%, 250mg

2-Butanona, min 99,5%, para síntesis, 1L, envase de vidrio

(1-Bromo-2,2,2-trifluoro-ethyl)-benzene, 95.0%, 250mg

Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate, 95.0%, 10g

H-DL-Lys-OH, 95.0%, 100g

2-Methyl-1-naphthoic acid, 98.0%, 100mg